Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,167) with videos related to
Page
of 117
Sort By:
Gynecologic Oncology
|
April 2, 2015
A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study
Chun-Chieh Wang, Hung-Hsueh Chou, Lan-Yan Yang, et al.
Journal of Gynecologic Oncology
|
February 1, 2024
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, et al.
Plos One
|
July 7, 2011
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells
Yun-Ju Chen, Wei-Chien Huang, Ya-Ling Wei, et al.
The Journal of Biological Chemistry
|
April 14, 2011
Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells
Wei-Chien Huang, Yun-Ju Chen, Long-Yuan Li, et al.
Gynecologic Oncology
|
August 9, 2016
Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology
Angel Chao, Ren-Chin Wu, Shih-Ming Jung, et al.
Biomedicines
|
July 29, 2023
Comparative Study of the Cytokine Profiles of Serum and Tissues from Patients with the Ossification of the Posterior Longitudinal Ligament
Li-Yu Fay, Chao-Hung Kuo, Hsuan-Kan Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2004
Defining the priority of using 18F-FDG PET for recurrent cervical cancer
Tzu-Chen Yen, Lai-Chu See, Ting-Chang Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 11, 2019
Management and clinical outcomes of patients with recurrent/progressive ovarian clear cell carcinoma
Huei-Jean Huang, Lan-Yan Yang, Hsiu-Jung Tung, et al.
British Journal of Cancer
|
August 4, 2018
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
Yoichi Aoki, Kazunori Ochiai, Soyi Lim, et al.
Plos One
|
December 5, 2013
Beclin 1 deficiency correlated with lymph node metastasis, predicts a distinct outcome in intrahepatic and extrahepatic cholangiocarcinoma
Tian-Tian Wang, Qing-Hua Cao, Ming-Yuan Chen, et al.
Page
of 117
Search research articles
Search
Showing results (1121-1130 of 1,167) with videos related to
Sort By:
Page
of 117
Gynecologic Oncology
|
April 2, 2015
A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study
Chun-Chieh Wang, Hung-Hsueh Chou, Lan-Yan Yang, et al.
Journal of Gynecologic Oncology
|
February 1, 2024
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, et al.
Plos One
|
July 7, 2011
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells
Yun-Ju Chen, Wei-Chien Huang, Ya-Ling Wei, et al.
The Journal of Biological Chemistry
|
April 14, 2011
Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells
Wei-Chien Huang, Yun-Ju Chen, Long-Yuan Li, et al.
Gynecologic Oncology
|
August 9, 2016
Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology
Angel Chao, Ren-Chin Wu, Shih-Ming Jung, et al.
Biomedicines
|
July 29, 2023
Comparative Study of the Cytokine Profiles of Serum and Tissues from Patients with the Ossification of the Posterior Longitudinal Ligament
Li-Yu Fay, Chao-Hung Kuo, Hsuan-Kan Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2004
Defining the priority of using 18F-FDG PET for recurrent cervical cancer
Tzu-Chen Yen, Lai-Chu See, Ting-Chang Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 11, 2019
Management and clinical outcomes of patients with recurrent/progressive ovarian clear cell carcinoma
Huei-Jean Huang, Lan-Yan Yang, Hsiu-Jung Tung, et al.
British Journal of Cancer
|
August 4, 2018
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
Yoichi Aoki, Kazunori Ochiai, Soyi Lim, et al.
Plos One
|
December 5, 2013
Beclin 1 deficiency correlated with lymph node metastasis, predicts a distinct outcome in intrahepatic and extrahepatic cholangiocarcinoma
Tian-Tian Wang, Qing-Hua Cao, Ming-Yuan Chen, et al.
Page
of 117